As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the treatment of adolescent obesity. In particular, semaglutide (Wegovy) plus ...
Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...
LOS ANGELES (KABC) -- Many people taking a popular diabetes medication have been experiencing weight loss as one of the side effects. Low blood sugar levels brought 59-year-old Anda Lam to her ...
If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold under the brand names Victoza and Saxenda. Read on for everything you need ...
Insulin glargine and the GLP-1 receptor agonist liraglutide are more effective at achieving an HbA1c of less than 7% than the sulfonylurea glimepiride or the DPP-IV inhibitor sitagliptin, according to ...
Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...
A popular new class of medications sheds pounds, treats diabetes and reduces heart disease risk. Can these drugs also protect the brain from memory and thinking problems? People who took Novo ...
World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...
The glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the phase 3a SCALE-KIDS trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results